Skip to content
Home/Companies/Healthcare/Intarcia Therapeutics
IT

Intarcia Therapeutics

Healthcare·US·Active·1yr hold

Intarcia Therapeutics is a healthcare company, headquartered in USA.

Entry
2025
Hold
1yr
Status
Active
Est. EV
–

Who owns Intarcia Therapeutics?

Intarcia Therapeutics is currently owned by Quilvest Capital Partners through QCP Buyout Fund III (2025 vintage), since 2025.

Hand-verified · updated 2026-04-21

Quilvest Capital Partners
Investor
Quilvest Capital Partners
QCP Buyout Fund III · 2025 · Buyout

Key facts

HQUSA
SectorHealthcare

More from QCP Buyout Fund III

Other portfolio companies in the same fund.

Acuiti Labs
Active
TMTFrance· 2025
Cabaia
Active
ConsumerFrance· 2025
EDH Group
Active
IndustrialsFrance· 2025
Ermitage
Active
ConsumerFrance· 2025
Fullers Foods
Active
ConsumerFrance· 2025
FundamentalCo
Active
Business ServicesUS· 2025

More PE-backed in Healthcare

Comparable healthcare deals from other GPs.

3i – Implant Innovations Inc.
Active
Advent InternationalUS
A Place for Mom
Active
Silver LakeUS
Abacus Pharmaceuticals
Active
The Carlyle GroupUS
Abbisko Healthcare
Active
The Carlyle GroupChina
Abode Healthcare
Active
Summit PartnersUS
AccentCare
Active
Advent InternationalUS
Data refreshed weekly · Sourced from public filings